Hemab Therapeutics Holdings, Inc.
COAG
$54.94
$0.991.84%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -24.15M | -22.69M | -12.21M | ||
| Total Depreciation and Amortization | 75.00K | 73.00K | 77.00K | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 856.00K | 655.00K | -777.00K | ||
| Change in Net Operating Assets | 582.00K | 375.00K | -2.42M | ||
| Cash from Operations | -22.64M | -21.58M | -15.33M | ||
| Capital Expenditure | -23.00K | -112.00K | 0.00 | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -107.41M | -15.74M | 21.50M | ||
| Cash from Investing | -107.44M | -15.85M | 21.50M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | 0.00 | -46.00K | -30.00K | ||
| Issuance of Common Stock | 317.17M | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 414.00K | -414.00K | -- | ||
| Cash from Financing | 317.58M | -460.00K | -30.00K | ||
| Foreign Exchange rate Adjustments | 1.00K | -223.00K | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 187.51M | -38.11M | 6.14M | ||